AGFA-GEVAERT NV (AGFB.BR) Fundamental Analysis & Valuation

EBR:AGFB • BE0003755692

Current stock price

0.484 EUR
+0 (+0.52%)
Last:

This AGFB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AGFB.BR Profitability Analysis

1.1 Basic Checks

  • AGFB had negative earnings in the past year.
  • AGFB had a positive operating cash flow in the past year.
  • In the past 5 years AGFB always reported negative net income.
  • AGFB had negative operating cash flow in 4 of the past 5 years.
AGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFAGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

1.2 Ratios

  • AGFB has a worse Return On Assets (-5.64%) than 66.67% of its industry peers.
  • AGFB has a worse Return On Equity (-28.35%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -5.64%
ROE -28.35%
ROIC N/A
ROA(3y)-6.57%
ROA(5y)-6.62%
ROE(3y)-27.45%
ROE(5y)-25.51%
ROIC(3y)N/A
ROIC(5y)N/A
AGFB.BR Yearly ROA, ROE, ROICAGFB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • AGFB has a worse Gross Margin (30.11%) than 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of AGFB has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for AGFB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.08%
GM growth 5Y0.88%
AGFB.BR Yearly Profit, Operating, Gross MarginsAGFB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. AGFB.BR Health Analysis

2.1 Basic Checks

  • AGFB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AGFB remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for AGFB has been reduced compared to 5 years ago.
  • AGFB has a worse debt/assets ratio than last year.
AGFB.BR Yearly Shares OutstandingAGFB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
AGFB.BR Yearly Total Debt VS Total AssetsAGFB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.19 indicates that AGFB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.19, AGFB perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
  • AGFB has a debt to FCF ratio of 5.83. This is a neutral value as AGFB would need 5.83 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.83, AGFB is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • AGFB has a Debt/Equity ratio of 0.60. This is a neutral value indicating AGFB is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.60, AGFB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.83
Altman-Z 2.19
ROIC/WACCN/A
WACC8.13%
AGFB.BR Yearly LT Debt VS Equity VS FCFAGFB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that AGFB should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.78, AGFB is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • AGFB has a Quick Ratio of 1.15. This is a normal value and indicates that AGFB is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.15, AGFB is in line with its industry, outperforming 41.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.15
AGFB.BR Yearly Current Assets VS Current LiabilitesAGFB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. AGFB.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.59% over the past year.
  • AGFB shows a decrease in Revenue. In the last year, the revenue decreased by -4.57%.
  • AGFB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.67% yearly.
EPS 1Y (TTM)16.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.26%
Revenue 1Y (TTM)-4.57%
Revenue growth 3Y-1.75%
Revenue growth 5Y-8.67%
Sales Q2Q%-5.85%

3.2 Future

  • AGFB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.35% yearly.
  • Based on estimates for the next years, AGFB will show a decrease in Revenue. The Revenue will decrease by -0.09% on average per year.
EPS Next Y123.08%
EPS Next 2Y73.21%
EPS Next 3Y42.35%
EPS Next 5YN/A
Revenue Next Year-2.06%
Revenue Next 2Y0.98%
Revenue Next 3Y-0.09%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGFB.BR Yearly Revenue VS EstimatesAGFB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AGFB.BR Yearly EPS VS EstimatesAGFB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

5

4. AGFB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AGFB. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 15.82, which indicates a correct valuation of AGFB.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AGFB indicates a rather cheap valuation: AGFB is cheaper than 83.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.62, AGFB is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.82
AGFB.BR Price Earnings VS Forward Price EarningsAGFB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • AGFB's Enterprise Value to EBITDA is on the same level as the industry average.
  • 91.67% of the companies in the same industry are more expensive than AGFB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.58
EV/EBITDA 152.55
AGFB.BR Per share dataAGFB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AGFB's earnings are expected to grow with 42.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3Y42.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AGFB.BR Dividend Analysis

5.1 Amount

  • No dividends for AGFB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AGFB.BR Fundamentals: All Metrics, Ratios and Statistics

AGFA-GEVAERT NV

EBR:AGFB (4/23/2026, 4:39:00 PM)

0.484

+0 (+0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-11
Earnings (Next)05-12
Inst Owners47.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap74.93M
Revenue(TTM)1.09B
Net Income(TTM)-72.00M
Analysts40
Price Target0.71 (46.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.65%
Min Revenue beat(2)-10.18%
Max Revenue beat(2)-7.11%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-19.23%
PT rev (3m)-19.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-40%
EPS NY rev (3m)-40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.19%
Revenue NY rev (3m)-3.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.82
P/S 0.07
P/FCF 2.58
P/OCF 1.19
P/B 0.3
P/tB 4.68
EV/EBITDA 152.55
EPS(TTM)-0.48
EYN/A
EPS(NY)0.03
Fwd EY6.32%
FCF(TTM)0.19
FCFY38.7%
OCF(TTM)0.41
OCFY84.08%
SpS7.01
BVpS1.64
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -5.64%
ROE -28.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.11%
FCFM 2.67%
ROA(3y)-6.57%
ROA(5y)-6.62%
ROE(3y)-27.45%
ROE(5y)-25.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.08%
GM growth 5Y0.88%
F-Score4
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.83
Debt/EBITDA 152
Cap/Depr 94.44%
Cap/Sales 3.13%
Interest Coverage N/A
Cash Conversion 6300%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.15
Altman-Z 2.19
F-Score4
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)92.38%
Cap/Depr(5y)74.29%
Cap/Sales(3y)3.35%
Cap/Sales(5y)2.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.26%
EPS Next Y123.08%
EPS Next 2Y73.21%
EPS Next 3Y42.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.57%
Revenue growth 3Y-1.75%
Revenue growth 5Y-8.67%
Sales Q2Q%-5.85%
Revenue Next Year-2.06%
Revenue Next 2Y0.98%
Revenue Next 3Y-0.09%
Revenue Next 5YN/A
EBIT growth 1Y28.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year521.05%
EBIT Next 3Y110.02%
EBIT Next 5YN/A
FCF growth 1Y159.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1675%
OCF growth 3YN/A
OCF growth 5YN/A

AGFA-GEVAERT NV / AGFB.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AGFA-GEVAERT NV?

ChartMill assigns a fundamental rating of 3 / 10 to AGFB.BR.


What is the valuation status for AGFB stock?

ChartMill assigns a valuation rating of 6 / 10 to AGFA-GEVAERT NV (AGFB.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for AGFA-GEVAERT NV?

AGFA-GEVAERT NV (AGFB.BR) has a profitability rating of 1 / 10.


How financially healthy is AGFA-GEVAERT NV?

The financial health rating of AGFA-GEVAERT NV (AGFB.BR) is 4 / 10.